A density-functional model for controlled release.

Timothy J Kosto; E Bruce Nauman

doi:10.1016/j.jconrel.2003.08.018

Home/Archive/PubMed

PubMed · 14644580

A density-functional model for controlled release.

Timothy J Kosto·E Bruce Nauman

View original source ↗Export metadata ↓

Abstract

Polymer diffusion based on density-functional theory is applied to controlled release systems. These models explicitly treat the multiphase characteristics of biomolecule-polymer composites typical of drug delivery devices. Polymer diffusion was modeled using the modified Cahn-Hilliard equation with periodic boundary conditions in one dimension and near-zero concentration boundaries in the second dimension. The diffusional driving forces are differences in chemical potential based in part on the Flory-Huggins free energy of mixing in polymer systems rather than concentration gradients. Release rates from this model were compared to exponential models typically used in the drug delivery literature. Simulations based on this model showed that the diffusional exponent is 1/2; this exponent is consistent with Fickian models at early times. Particle growth, which also occurs in diffusing, dispersed systems, was observed. The particle growth exponent in these systems was 2/3, twice the value typical in bulk ripening systems. The increased growth rate was caused by the elimination of small particles due to diffusion out of the system, which removed the low particle size region of the distribution faster than ripening alone.

Explore related subjects

Delayed-Action Preparations Models, Theoretical Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Timothy J Kosto, E Bruce Nauman. 2003-12-12. A density-functional model for controlled release.. https://doi.org/10.1016/j.jconrel.2003.08.018

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Mathematical modeling and in vitro study of controlled drug release via a highly swellable and dissoluble polymer matrix: polyethylene oxide with high molecular weights.

A mathematical model is developed to describe the transport phenomena of a water-soluble small molecular drug (caffeine) from highly swellable and dissoluble polyethylene oxide (PEO) cylindrical tablets. Several important aspects in drug release kinetics were taken into account simultaneously in this theoretical model: swelling of the hydrophilic matrix and water penetration, three-dimensional and concentration-dependent diffusion of drug and water, and polymer dissolution. The moving boundary conditions are explicitly derived, and the resulting coupled partial differential equations are solved numerically. In vitro study of swelling, dissolution behavior of PEOs with different molecular weights and drug release are also carried out. When compared with experimental results, this theoretical model agrees with the water uptake, dimensional change and polymer dissolution profiles very well for pure PEO tablets with two different molecular weights. Drug release profiles using this model are predicted with a very good agreement with experimental data at different initial loadings. The overall drug release process is found to be highly dependent on the matrix swelling, drug and water diffusion, polymer dissolution and initial dimensions of the tablets. Their influences on drug release kinetics from PEO with two different molecular weights are also investigated.

Delayed-Action Preparations↗

PubMed2005

Novel polyelectrolyte carboxymethyl konjac glucomannan-chitosan nanoparticles for drug delivery. II. Release of albumin in vitro.

Carboxymethyl konjac glucomannan-chitosan (CKGM-CS) nanoparticles were spontaneously prepared under very mild conditions via polyelectrolyte complexation. Bovine serum albumin (BSA), as a model protein drug, was incorporated into the CKGM-CS nanoparticles. The physicochemical properties of the BSA-loaded nanoparticles were identified by Zetasizer 3000 and FTIR spectrophotometry. Their sizes were from 330 nm to 900 nm; zeta potentials were positive according to varies CKGM/CS ratios. The encapsulation efficiency was up 20%. The release behavior in vitro of BSA from the nanoparticles was also investigated. We could find that the BSA release from the CKGM-CS nanoparticles is much more influenced by the CS coating layer than by the CKGM inner structure. And the CKGM-CS matrices not only exhibited pH-responsive properties, but ionic strength-sensitive properties. These systems may present a potential for pulsatile protein drug delivery.

Delayed-Action Preparations↗

PubMed2005

In brief: Mucinex.

Mucinex is the old drug guaifenesin in an new FSA-approved OTC extended-release formulation. In recommended dosages, it is generally regarded as safe. Medical Letter consultants have not been impressed by guaifenesin's effectiveness in older formulations.

Delayed-Action Preparations↗